Developer docs
API playgroundTry for free, no card

Search company profiles

VirtuOx

Full company profile

uuid0007tc9

Namestring
VirtuOx
Legal namestring
VirtuOx, Inc.
Websiteurl
virtuox.net
Company typeenum
Private
Founded yearint
2005
Descriptiontext

VirtuOx, Inc. is a US-based healthcare information technology company founded in 2005 and headquartered in Coral Springs, Florida, that provides vertically integrated home-based diagnostic testing and patient monitoring services. The company operates a proprietary HIPAA-compliant platform that ingests biometric data from a portfolio of FDA-cleared medical devices—including the NightOwl Mini disposable HSAT, the VPOD family of oximeters (Ultra, Dream, Handheld Pro, Capox, Vital Pro), the RhythmStar mobile cardiac telemetry monitor, and the Sleep Profiler PSG2—and uses AI-powered algorithms to convert that data into clinical reports for physician review. VirtuOx is accredited by The Joint Commission as an Ambulatory Care Sleep Diagnostic Center and certified by Medicare as an Independent Diagnostic Testing Facility (IDTF), enabling it to bill CMS and commercial payors under CPT codes G0400, G0399, and G0398. The company performs over 40,000 new diagnostic tests per month and has cumulatively served more than 6 million patients, 250,000+ referring physicians, and 4,000+ DME (Durable Medical Equipment) partners since founding.

VirtuOx serves three primary customer segments: individual consumers seeking convenient at-home sleep, cardiac, insomnia, and hypoxemia testing; healthcare professionals (physicians, sleep specialists, cardiologists, pulmonologists) who order and interpret diagnostic tests; and DME providers requiring overnight oximetry to qualify patients for home oxygen therapy under CMS requirements. The company monetizes through insurance- and Medicare-reimbursed diagnostic testing services, proprietary device sales to healthcare providers and DME partners, and the Sleepifi SaaS platform, which bundles HSAT software, devices, and logistics for physician practices and sleep labs on a subscription basis.

In May 2025, ResMed (NYSE: RMD) acquired VirtuOx to integrate its virtual home-based diagnostic testing platform into ResMed's broader sleep and respiratory care ecosystem. VirtuOx continues to operate as a fully owned subsidiary under its existing brand, retaining its leadership team. The acquisition was described by ResMed as not material to its financial results, implying VirtuOx sits in the sub-$100M revenue range.

Short descriptiontext

VirtuOx is a Coral Springs, Florida-based healthcare IT company founded in 2005 that operates a HIPAA-compliant platform for home-based sleep apnea, cardiac, respiratory, and insomnia diagnostics. It serves consumers directly, 250,000+ referring physicians, and 4,000+ DME partners, and operates as a ResMed subsidiary following its May 2025 acquisition.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersCoral Springs, United States
HQ citystring
Coral Springs
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
home sleep apnea testing, diagnostic testing services, medical oximetry devices, cardiac telemetry monitoring, healthcare SaaS platform
Industry4 codes
PRIMARYHLAHAGAB
Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLALAGAF
Pulmonology & Sleep Medicine Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLAFAKAF
Sleep Diagnostic Centers (Polysomnography)
SECONDARYHLALAAAE
At-Home Lab Testing & Diagnostics-Integrated Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
NAICS code2 codes
  • Medical and Diagnostic Laboratories62151
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Home Diagnostic Testing Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Diagnostic Testing Services
TypeSubscription Recurring
Description

VirtuOx provides diagnostic testing services for sleep apnea, respiratory conditions, cardiac monitoring, and insomnia. Services are billed to insurance and Medicare. Performs 40,000+ diagnostic tests per month.

virtuox.net
2SaaS and Software Solutions
TypeSubscription Recurring
Description

Provides SaaS solutions for healthcare providers including Sleepifi software for home sleep apnea testing logistics and device management.

virtuox.net
3Device Sales
TypeHardware Sales
Description

Sells proprietary medical devices including oximeters and diagnostic equipment to healthcare providers and DME partners.

virtuox.net
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Pricing details1 tier
1Diagnostic testing covered by insurance and Medicare
ModelSubscriptionBilling cadenceMonthly
Notes

Most insurance plans and Medicare cover VirtuOx diagnostic services. Specific CPT codes G0400, G0399, G0398 are used for billing.

virtuox.net
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 record
1Sleepifi
Description

Home sleep apnea testing software, device, and logistics solutions for healthcare providers

virtuox.net
Core offering1 text field

VirtuOx provides at-home diagnostic testing and patient monitoring services covering sleep apnea, insomnia, cardiac arrhythmia, and hypoxemia, delivered through proprietary FDA-cleared medical devices, the Sleepifi SaaS platform, and a HIPAA-compliant AI-powered web platform that converts biometric sensor data into physician-ready diagnostic reports. The company serves both individual consumers via direct online scheduling and healthcare providers (physicians, sleep labs, DME partners) via its enterprise software and logistics solutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Cuts average time to diagnose OSA in half compared to traditional lab testing
+4 more records
Product overview1 text field

VirtuOx is a healthcare information technology company that provides vertically integrated diagnostic tools and services enabling healthcare organizations to diagnose and treat diseases. The company operates as a platform of interconnected products spanning sleep apnea testing (NightOwl Mini disposable HSAT, Sleep Profiler PSG2, Alice NightOne, ApneaLink Air), overnight oximetry (VPOD Ultra/Dream/Handheld Pro/Capox/Vital Pro devices), cardiac monitoring (RhythmStar wearable cardiac monitor), and insomnia testing (wearable EEG-based sleep profiler). The Sleepifi SaaS platform provides software, devices, and logistics solutions for healthcare providers offering HSAT. Diagnostic data from all devices is transmitted to VirtuOx's proprietary HIPAA-compliant platform where AI-powered algorithms compile data into meaningful reports. The company serves consumers directly and healthcare professionals through integrated platforms, having served over 6 million patients, 250,000+ referring physicians, and 4,000+ DME partners since 2005. VirtuOx operates as a fully owned subsidiary of ResMed following acquisition in May 2025.

Product and service15 records
1NightOwl Mini
CategoryHome Sleep Apnea Testing Device
Description

Single-patient, multi-night, disposable home sleep apnea test (HSAT) device capable of recording up to 12 nights, auto-scored with clinically validated algorithms equivalent to PSG. Used by healthcare professionals for at-home sleep apnea diagnosis.

2VPOD Ultra
CategoryOximetry Device
Description

FDA-cleared overnight pulse oximeter with High Resolution Pulse Oximetry (HRPO) recording at 1-second intervals, 60 hours of data storage, USB interface, and Good Study Indicator. Used for overnight oximetry and home oxygen qualification testing.

3VPOD Dream
CategoryOximetry Device
Description

Compact overnight pulse oximeter weighing less than 0.26 kg that measures SpO2, heart rate, pulse rate, respiratory rate, body position, and sleep time. Features VirtuMove SpO2 motion and low-perfusion artifact removal.

4VPOD Handheld Pro
CategoryOximetry Device
Description

Handheld pulse oximeter with TFT color display, clinical lock menu, high/low alarms for SpO2/HR, and low perfusion index reporting. Suitable for adult, pediatric and neonatal use in clinics, hospitals, home medical equipment companies, ambulances, and sleep labs.

5VPOD Capox
CategoryOximetry Device
Description

Capnography and pulse oximetry device with 2.8 inch TFT monitoring EtCO2/CO2, RR, SpO2, and PR. Features temperature and pressure compensation, water filter, audio/visual alarms, and up to 72 hours of data recording.

6VPOD Vital Pro
CategoryVital Signs Monitor
Description

Comprehensive vital signs monitor with rechargeable lithium ion battery and finger probe, used for screening NIV patients or validating NIV settings.

7RhythmStar
CategoryCardiac Monitoring Device
Description

Wearable cardiac monitor with built-in 4G LTE CAT-M1 cellular connectivity, recording 30-day continuous ECG with 18-bit ADC resolution at 256 Hz sampling and including a 3-axis accelerometer. Improves patient compliance and arrhythmia detection for mobile cardiac telemetry.

8Sleep Profiler PSG2
CategoryPolysomnography System
Description

13-channel polysomnography (PSG) system enabling unattended PSG studies for patients with co-morbidities, those unable to sleep in lab, or those suspected of upper airway resistance syndrome or neurodegenerative disease. Includes EEG, EOG, EMG, wireless oximetry, nasal pressure/airflow, chest and abdomen respiratory effort, pulse rate, head movement, and quantitative snoring.

9Alice NightOne
CategoryHome Sleep Apnea Testing Device
Description

Type III HSAT device recording four channels: respiratory effort, pulse, oxygen saturation, and nasal flow, used for home sleep apnea testing.

10ApneaLink Air
CategoryHome Sleep Apnea Testing Device
Description

Type III HSAT device recording four channels: respiratory effort, pulse, oxygen saturation, and nasal flow, used for home sleep apnea testing.

11Sleepifi
CategoryHealthcare SaaS Platform
Description

SaaS solution providing home sleep apnea testing software, devices, and logistics for healthcare providers and sleep labs. Allows providers to offer HSAT without purchasing devices, handling shipping/receiving, or providing 24/7 technical support.

12VirtuOx Oxygen Qualification Testing
CategoryDiagnostic Testing Service
Description

Overnight oximetry testing service that supports Medicare home oxygen therapy qualification. DME providers act as couriers of oximetry devices to and from patients' homes, with data transmitted to VirtuOx's HIPAA-compliant servers for report generation.

13VirtuOx Home Sleep Testing
CategoryDiagnostic Testing Service
Description

Home sleep apnea testing service with multiple device options (NightOwl Mini, Alice NightOne, ApneaLink Air, Sleep Profiler PSG2) offering summary, detail, and interpretation reports. Fast, affordable, and convenient in-home testing covered by most insurance and Medicare.

14VirtuOx Insomnia Testing
CategoryDiagnostic Testing Service
Description

At-home insomnia testing using a wearable device designed to assess sleep architecture and sleep continuity. Enables physicians to formally diagnose insomnia and determine severity for treatment planning.

15VirtuOx Mobile Cardiac Telemetry
CategoryRemote Cardiac Monitoring Service
Description

Remote cardiac monitoring service using the RhythmStar device with 24/7 monitoring center staffed by Certified Cardiographic Technicians (CCT) and Certified Rhythm Analysis Technicians (CRAT). Detects abnormal heart rhythms difficult to capture during office visits.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-01
Description

ResMed (NYSE: RMD), a global health technology company focused on sleep and breathing care, acquired VirtuOx in May 2025. The acquisition integrates VirtuOx's virtual testing platform into ResMed's ecosystem to address diagnostic bottlenecks in sleep apnea care. VirtuOx operates as a fully owned subsidiary under its existing brand while retaining its leadership team. The deal was not material to ResMed's financial results.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Compumedics is a global manufacturer of PSG, HSAT, and EEG diagnostic systems. Its Somté, Safiro, and other products compete with VirtuOx's polysomnography and home sleep testing device lines for sleep lab customers.

TypeBroad incumbent
Description

ResMed is now VirtuOx's parent company and the global leader in sleep-disordered breathing and CPAP. Its ApneaLink Air, AirView, and broader connected-care platform overlap with VirtuOx's HSAT and SaaS offerings at the corporate level.

3Lofta
TypeDirect peer
Description

Lofta is a direct-to-consumer home sleep apnea testing and CPAP provider. It overlaps with VirtuOx's consumer-facing HSAT scheduling, telemedicine workflow, and sleep apnea diagnostic service line.

TypeEmerging player
Description

Signifier Medical Technologies markets eXciteOSA, a daytime neuromuscular stimulation therapy for mild OSA. It is a niche emerging player in sleep-disordered breathing that intersects with VirtuOx's diagnostic funnel into treatment.

TypeOthers
Description

Withings Health Solutions offers connected sleep and vital-sign monitoring devices and data platforms to providers and payers. It is thematically adjacent to VirtuOx's at-home biometric monitoring and AI-driven diagnostic reporting model.

TypeDirect peer
Description

ApneaMed is an independent diagnostic testing facility specializing in home sleep apnea testing, very similar in business model to VirtuOx. It competes for the same DME partner referrals and physician prescription volume.

TypeDirect peer
Description

Cadwell manufactures PSG and EEG/neurodiagnostic equipment used by sleep centers and neurologists. Its Easy III PSG and related hardware overlap with VirtuOx's Sleep Profiler PSG2 unattended study offering.

TypeDirect peer
Description

CleveMed manufactures SleepView and other home sleep apnea testing devices used by sleep labs and IDTFs. It competes directly with VirtuOx's NightOwl Mini, Alice NightOne, and Sleep Profiler HSAT/PSG portfolio in the home-based diagnostic channel.

TypeBroad incumbent
Description

Itamar Medical's WatchPAT is a widely used disposable HSAT device with auto-scoring. Following its acquisition by ZOLL Itamar is now part of the broader ResMed ecosystem, making it both a competitor and increasingly an internal ResMed peer to VirtuOx.

TypeDirect peer
Description

Nox Medical manufactures Nox T3 and other ambulatory PSG/HSAT recorders used by sleep labs worldwide. It is comparable to VirtuOx's Sleep Profiler PSG2 and Alice NightOne products on the device side.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

VirtuOx

Home Diagnostic Testing Servicesvirtuox.net

VirtuOx is a Coral Springs, Florida-based healthcare IT company founded in 2005 that operates a HIPAA-compliant platform for home-based sleep apnea, cardiac, respiratory, and insomnia diagnostics. It serves consumers directly, 250,000+ referring physicians, and 4,000+ DME partners, and operates as a ResMed subsidiary following its May 2025 acquisition.

What VirtuOx does

VirtuOx, Inc. is a US-based healthcare information technology company founded in 2005 and headquartered in Coral Springs, Florida, that provides vertically integrated home-based diagnostic testing and patient monitoring services. The company operates a proprietary HIPAA-compliant platform that ingests biometric data from a portfolio of FDA-cleared medical devices—including the NightOwl Mini disposable HSAT, the VPOD family of oximeters (Ultra, Dream, Handheld Pro, Capox, Vital Pro), the RhythmStar mobile cardiac telemetry monitor, and the Sleep Profiler PSG2—and uses AI-powered algorithms to convert that data into clinical reports for physician review. VirtuOx is accredited by The Joint Commission as an Ambulatory Care Sleep Diagnostic Center and certified by Medicare as an Independent Diagnostic Testing Facility (IDTF), enabling it to bill CMS and commercial payors under CPT codes G0400, G0399, and G0398. The company performs over 40,000 new diagnostic tests per month and has cumulatively served more than 6 million patients, 250,000+ referring physicians, and 4,000+ DME (Durable Medical Equipment) partners since founding.

VirtuOx serves three primary customer segments: individual consumers seeking convenient at-home sleep, cardiac, insomnia, and hypoxemia testing; healthcare professionals (physicians, sleep specialists, cardiologists, pulmonologists) who order and interpret diagnostic tests; and DME providers requiring overnight oximetry to qualify patients for home oxygen therapy under CMS requirements. The company monetizes through insurance- and Medicare-reimbursed diagnostic testing services, proprietary device sales to healthcare providers and DME partners, and the Sleepifi SaaS platform, which bundles HSAT software, devices, and logistics for physician practices and sleep labs on a subscription basis.

In May 2025, ResMed (NYSE: RMD) acquired VirtuOx to integrate its virtual home-based diagnostic testing platform into ResMed's broader sleep and respiratory care ecosystem. VirtuOx continues to operate as a fully owned subsidiary under its existing brand, retaining its leadership team. The acquisition was described by ResMed as not material to its financial results, implying VirtuOx sits in the sub-$100M revenue range.

VirtuOx firmographics

Firmographics
Name
VirtuOx
Legal name
VirtuOx, Inc.
Website
https://virtuox.net
Company type
Private
Founded year
2005
Operating status
Acquired
Headcount range
101–250 employees
Short description
VirtuOx is a Coral Springs, Florida-based healthcare IT company founded in 2005 that operates a HIPAA-compliant platform for home-based sleep apnea, cardiac, respiratory, and insomnia diagnostics. It serves consumers directly, 250,000+ referring physicians, and 4,000+ DME partners, and operates as a ResMed subsidiary following its May 2025 acquisition.
Ownership category
akta.pro rank

VirtuOx industry classification

Industry
Product category
Home Diagnostic Testing Services
NAICS
Medical and Diagnostic Laboratories (62151), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAGAB
Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLALAGAF
Pulmonology & Sleep Medicine Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLAFAKAF
Sleep Diagnostic Centers (Polysomnography)
SECONDARYHLALAAAE
At-Home Lab Testing & Diagnostics-Integrated Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms

Keywords

  • Home sleep apnea testing
  • Diagnostic testing services
  • Medical oximetry devices
  • Cardiac telemetry monitoring
  • Healthcare SaaS platform

Where VirtuOx is headquartered

Location

Headquarters

HQ city
Coral Springs
HQ country
United States
HQ region
North America

Offices1 record

Markets served

VirtuOx business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Diagnostic Testing Services: VirtuOx provides diagnostic testing services for sleep apnea, respiratory conditions, cardiac monitoring, and insomnia. Services are billed to insurance and Medicare. Performs 40,000+ diagnostic tests per month.
  2. SaaS and Software Solutions: Provides SaaS solutions for healthcare providers including Sleepifi software for home sleep apnea testing logistics and device management.
  3. Device Sales: Sells proprietary medical devices including oximeters and diagnostic equipment to healthcare providers and DME partners.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyDiagnostic testing covered by insurance and Medicare

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

VirtuOx product offering

Product offering

Core offering

VirtuOx provides at-home diagnostic testing and patient monitoring services covering sleep apnea, insomnia, cardiac arrhythmia, and hypoxemia, delivered through proprietary FDA-cleared medical devices, the Sleepifi SaaS platform, and a HIPAA-compliant AI-powered web platform that converts biometric sensor data into physician-ready diagnostic reports. The company serves both individual consumers via direct online scheduling and healthcare providers (physicians, sleep labs, DME partners) via its enterprise software and logistics solutions.

Product overview

VirtuOx is a healthcare information technology company that provides vertically integrated diagnostic tools and services enabling healthcare organizations to diagnose and treat diseases. The company operates as a platform of interconnected products spanning sleep apnea testing (NightOwl Mini disposable HSAT, Sleep Profiler PSG2, Alice NightOne, ApneaLink Air), overnight oximetry (VPOD Ultra/Dream/Handheld Pro/Capox/Vital Pro devices), cardiac monitoring (RhythmStar wearable cardiac monitor), and insomnia testing (wearable EEG-based sleep profiler). The Sleepifi SaaS platform provides software, devices, and logistics solutions for healthcare providers offering HSAT. Diagnostic data from all devices is transmitted to VirtuOx's proprietary HIPAA-compliant platform where AI-powered algorithms compile data into meaningful reports. The company serves consumers directly and healthcare professionals through integrated platforms, having served over 6 million patients, 250,000+ referring physicians, and 4,000+ DME partners since 2005. VirtuOx operates as a fully owned subsidiary of ResMed following acquisition in May 2025.

Differentiator

Problem solved

Functional benefit

Brands

  • Sleepifi: Home sleep apnea testing software, device, and logistics solutions for healthcare providers

Products and services

  • NightOwl Mini Single-patient, multi-night, disposable home sleep apnea test (HSAT) device capable of recording up to 12 nights, auto-scored with clinically validated algorithms equivalent to PSG. Used by healthcare professionals for at-home sleep apnea diagnosis.
  • VPOD Ultra FDA-cleared overnight pulse oximeter with High Resolution Pulse Oximetry (HRPO) recording at 1-second intervals, 60 hours of data storage, USB interface, and Good Study Indicator. Used for overnight oximetry and home oxygen qualification testing.
  • VPOD Dream Compact overnight pulse oximeter weighing less than 0.26 kg that measures SpO2, heart rate, pulse rate, respiratory rate, body position, and sleep time. Features VirtuMove SpO2 motion and low-perfusion artifact removal.
  • VPOD Handheld Pro Handheld pulse oximeter with TFT color display, clinical lock menu, high/low alarms for SpO2/HR, and low perfusion index reporting. Suitable for adult, pediatric and neonatal use in clinics, hospitals, home medical equipment companies, ambulances, and sleep labs.
  • VPOD Capox Capnography and pulse oximetry device with 2.8 inch TFT monitoring EtCO2/CO2, RR, SpO2, and PR. Features temperature and pressure compensation, water filter, audio/visual alarms, and up to 72 hours of data recording.
  • VPOD Vital Pro Comprehensive vital signs monitor with rechargeable lithium ion battery and finger probe, used for screening NIV patients or validating NIV settings.
  • RhythmStar Wearable cardiac monitor with built-in 4G LTE CAT-M1 cellular connectivity, recording 30-day continuous ECG with 18-bit ADC resolution at 256 Hz sampling and including a 3-axis accelerometer. Improves patient compliance and arrhythmia detection for mobile cardiac telemetry.
  • Sleep Profiler PSG2 13-channel polysomnography (PSG) system enabling unattended PSG studies for patients with co-morbidities, those unable to sleep in lab, or those suspected of upper airway resistance syndrome or neurodegenerative disease. Includes EEG, EOG, EMG, wireless oximetry, nasal pressure/airflow, chest and abdomen respiratory effort, pulse rate, head movement, and quantitative snoring.
  • Alice NightOne Type III HSAT device recording four channels: respiratory effort, pulse, oxygen saturation, and nasal flow, used for home sleep apnea testing.
  • ApneaLink Air Type III HSAT device recording four channels: respiratory effort, pulse, oxygen saturation, and nasal flow, used for home sleep apnea testing.
  • Sleepifi SaaS solution providing home sleep apnea testing software, devices, and logistics for healthcare providers and sleep labs. Allows providers to offer HSAT without purchasing devices, handling shipping/receiving, or providing 24/7 technical support.
  • VirtuOx Oxygen Qualification Testing Overnight oximetry testing service that supports Medicare home oxygen therapy qualification. DME providers act as couriers of oximetry devices to and from patients' homes, with data transmitted to VirtuOx's HIPAA-compliant servers for report generation.
  • VirtuOx Home Sleep Testing Home sleep apnea testing service with multiple device options (NightOwl Mini, Alice NightOne, ApneaLink Air, Sleep Profiler PSG2) offering summary, detail, and interpretation reports. Fast, affordable, and convenient in-home testing covered by most insurance and Medicare.
  • VirtuOx Insomnia Testing At-home insomnia testing using a wearable device designed to assess sleep architecture and sleep continuity. Enables physicians to formally diagnose insomnia and determine severity for treatment planning.
  • VirtuOx Mobile Cardiac Telemetry Remote cardiac monitoring service using the RhythmStar device with 24/7 monitoring center staffed by Certified Cardiographic Technicians (CCT) and Certified Rhythm Analysis Technicians (CRAT). Detects abnormal heart rhythms difficult to capture during office visits.

Quantifiable outcome

  • Cuts average time to diagnose OSA in half compared to traditional lab testing
  • +4 more outcomes

Companies that use VirtuOx

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

VirtuOx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature7 records

VirtuOx partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • ResMedcoreStrategic or Co-development Partner · 1 May 2025ResMed (NYSE: RMD), a global health technology company focused on sleep and breathing care, acquired VirtuOx in May 2025. The acquisition integrates VirtuOx's virtual testing platform into ResMed's ecosystem to address diagnostic bottlenecks in sleep apnea care. VirtuOx operates as a fully owned subsidiary under its existing brand while retaining its leadership team. The deal was not material to ResMed's financial results.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

VirtuOx competitors and assessment

Company assessment

Direct peers

  • Compumedics: Compumedics is a global manufacturer of PSG, HSAT, and EEG diagnostic systems. Its Somté, Safiro, and other products compete with VirtuOx's polysomnography and home sleep testing device lines for sleep lab customers.
  • Lofta: Lofta is a direct-to-consumer home sleep apnea testing and CPAP provider. It overlaps with VirtuOx's consumer-facing HSAT scheduling, telemedicine workflow, and sleep apnea diagnostic service line.
  • ApneaMed (Watermark Medical): ApneaMed is an independent diagnostic testing facility specializing in home sleep apnea testing, very similar in business model to VirtuOx. It competes for the same DME partner referrals and physician prescription volume.
  • Cadwell Industries: Cadwell manufactures PSG and EEG/neurodiagnostic equipment used by sleep centers and neurologists. Its Easy III PSG and related hardware overlap with VirtuOx's Sleep Profiler PSG2 unattended study offering.
  • CleveMed: CleveMed manufactures SleepView and other home sleep apnea testing devices used by sleep labs and IDTFs. It competes directly with VirtuOx's NightOwl Mini, Alice NightOne, and Sleep Profiler HSAT/PSG portfolio in the home-based diagnostic channel.
  • Nox Medical: Nox Medical manufactures Nox T3 and other ambulatory PSG/HSAT recorders used by sleep labs worldwide. It is comparable to VirtuOx's Sleep Profiler PSG2 and Alice NightOne products on the device side.

Broad incumbents

  • ResMed: ResMed is now VirtuOx's parent company and the global leader in sleep-disordered breathing and CPAP. Its ApneaLink Air, AirView, and broader connected-care platform overlap with VirtuOx's HSAT and SaaS offerings at the corporate level.
  • Itamar Medical (ZOLL/ResMed WatchPAT): Itamar Medical's WatchPAT is a widely used disposable HSAT device with auto-scoring. Following its acquisition by ZOLL Itamar is now part of the broader ResMed ecosystem, making it both a competitor and increasingly an internal ResMed peer to VirtuOx.

Emerging players

  • Signifier Medical Technologies: Signifier Medical Technologies markets eXciteOSA, a daytime neuromuscular stimulation therapy for mild OSA. It is a niche emerging player in sleep-disordered breathing that intersects with VirtuOx's diagnostic funnel into treatment.

Others

  • Withings Health Solutions: Withings Health Solutions offers connected sleep and vital-sign monitoring devices and data platforms to providers and payers. It is thematically adjacent to VirtuOx's at-home biometric monitoring and AI-driven diagnostic reporting model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

VirtuOx social profiles

Digital presence

VirtuOx compliance and trust

Trust signal

Compliance2 records

VirtuOx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

VirtuOx leadership team

Management profile

Number of profiles

Profiles1 record

VirtuOx funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

VirtuOx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VirtuOx

What does VirtuOx do?

VirtuOx provides at-home diagnostic testing and patient monitoring services covering sleep apnea, insomnia, cardiac arrhythmia, and hypoxemia, delivered through proprietary FDA-cleared medical devices, the Sleepifi SaaS platform, and a HIPAA-compliant AI-powered web platform that converts biometric sensor data into physician-ready diagnostic reports. The company serves both individual consumers via direct online scheduling and healthcare providers (physicians, sleep labs, DME partners) via its enterprise software and logistics solutions.

Is VirtuOx a public or private company?

VirtuOx is a private company. It is classified as corporate owned and is currently acquired.

When was VirtuOx founded?

VirtuOx was founded in 2005. It employs 101 to 250 people.

Where is VirtuOx based?

VirtuOx is headquartered in Coral Springs, United States, in the North America region.

How does VirtuOx make money?

Three revenue lines are on record. Diagnostic Testing Services are the primary driver. The others are saaS and Software Solutions and device Sales.

Who are VirtuOx's main competitors?

Direct peers on record are Compumedics, Lofta, ApneaMed (Watermark Medical), Cadwell Industries, CleveMed and Nox Medical. Broad incumbents are ResMed and Itamar Medical (ZOLL/ResMed WatchPAT). Signifier Medical Technologies is listed as an emerging player. Withings Health Solutions is listed as an others.

Does VirtuOx have an API?

No public API is recorded for VirtuOx.

What industry is VirtuOx in?

VirtuOx's product category is Home Diagnostic Testing Services. Its primary akta.pro industry code is HLAHAGAB, Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy), with a secondary code of HLALAGAF, Pulmonology & Sleep Medicine Telemedicine Platforms. Its NAICS code is 62151 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MorningstarmHealth Solutions Market worth $275.44 billion by 2031 - Exclusive Report by MarketsandMarkets™MarketsandMarkets projects the mHealth solutions market to grow from $109.05 billion in 2026 to $275.44 billion by 2031, a CAGR of 20.4%. North America held the largest regional share in 2025, and chronic care management apps led the offering segment. Investment in remote monitoring and connected devices is increasing.openPR.comTrends in Growth, Segment Analysis, and Competitor Approaches Influencing the Respiratory Devices and Equipment (Diagnostic) MarketThe respiratory devices and equipment (diagnostic) market is projected to reach $13.29 billion by 2030, growing at a 9.7% CAGR, driven by advancements in diagnostic technologies, molecular testing adoption, and home-based monitoring solutions. In May 2025, ResMed Inc. acquired VirtuOx, a company specializing in virtual testing platforms for sleep-disordered breathing and respiratory conditions, to strengthen its virtual care and in-home diagnostic services. In December 2023, Thermo Fisher Scientific Inc. launched its Sample Preparation Solutions for respiratory diagnostic testing, including the KingFisher Apex Dx system for automated nucleic acid purification.EIN PresswireCardiometabolic-Sleep Comorbidity Treatment Market to Reach USD 20,362.40 Mn by 2036, Driven by Value-Base ReimbursementFuture Market Insights projects the global cardiometabolic-sleep comorbidity treatment market to grow from USD 7,850.60 million in 2026 to USD 20,362.40 million by 2036, representing a 10.0% CAGR, driven by value-based care reimbursement adoption and integrated care pathway models combining sleep medicine with cardiometabolic disease management. The UK NHS is already implementing this shift, targeting high-risk obstructive sleep apnea patients with lifestyle, weight, and behavioral sleep therapy over mass screening. Notable industry consolidation includes ResMed's acquisition of VirtuOx (May 2025) and Philips' expanded collaboration with Medtronic (June 2025), as companies build platform-based ecosystems combining devices, pharmaceuticals, and digital health solutions.EIN PresswireVirtual Sleep Clinics Market Projected to Surpass USD 5.5 Billion by 2036 as Remote Monitoring Redefine Sleep MedicineThe global virtual sleep clinics market is projected to grow from USD 1,250.4 million in 2026 to USD 5,516.1 million by 2036, representing a compound annual growth rate of 16.0%, driven by favorable reimbursement policies, AI integration in clinical workflows, and a shift toward home-based patient care. AI is reducing sleep study interpretation time from 45 minutes to under 10 minutes per case, while regulatory frameworks such as the U.S. Medicare Remote Patient Monitoring CPT codes and FDA clearances for diagnostic algorithms are creating sustainable revenue models. The competitive landscape is consolidating through vertical integration, with notable transactions including ResMed's acquisition of VirtuOx and Teladoc Health's acquisition of UpLift in 2025, signaling a shift toward unified sleep ecosystems.EIN PresswireVirtual Sleep Clinics Market Forecast 2026-2036: Market Size, Share, Competitive Landscape & Future Growth OutlookThe global virtual sleep clinics market reached an estimated valuation of USD 1.5 billion in early 2026, with analysts projecting continued growth at a CAGR of 16% through 2036, driven by rising sleep disorder prevalence and telehealth adoption. Key structural shifts include reimbursement expansion by Medicare and UnitedHealthcare, strategic M&A activity such as ResMed's acquisition of VirtuOx, and partnerships like Signifier Medical Technologies with Sunrise to capture the patient intake funnel. The market is transitioning from traditional lab-based polysomnography toward home-based diagnostics using FDA-cleared devices and AI-enhanced triage, with North America holding the largest share while Asia-Pacific emerges as the fastest-growing region.Persistence Market ResearchPatient Engagement Solution Market Size Report, 2032The global patient engagement solutions market is valued at US$19.1 billion in 2025 and is projected to reach US$47.5 billion by 2032, growing at a CAGR of 13.9%, driven by digital health adoption and patient-centric care models. North America leads with 37% market share due to advanced infrastructure and regulatory support like HIPAA, while Asia Pacific is the fastest-growing region at 14.3% CAGR. Key recent developments include ResMed's acquisition of VirtuOx in May 2025 to expand virtual care capabilities, and IKS Health's partnership with OrthoNY to deploy AI-powered patient engagement tools.Hme-businessResmed Acquires Diagnostic Testing Facility VirtuOxResmed (NYSE: RMD) has acquired VirtuOx, an independent diagnostic testing facility specializing in at-home testing for sleep, respiratory, and cardiac conditions, with the transaction announced May 1 and described as not material to Resmed's financial results. The acquisition integrates VirtuOx's virtual testing platform into Resmed's ecosystem to address diagnostic bottlenecks, particularly for sleep apnea where approximately 30 million Americans are affected but only 20% have been diagnosed. VirtuOx will operate as a fully owned Resmed subsidiary under its existing brand while retaining its leadership team.GlobeNewswireResmed Acquires VirtuOxResmed acquired VirtuOx, an independent diagnostic testing facility for sleep, respiratory, and cardiac conditions. The acquisition aims to streamline diagnostic pathways and expand home-based care, with financial terms undisclosed. VirtuOx will operate as a fully owned subsidiary.Stock TitanResmed Acquires VirtuOxResmed acquired VirtuOx, an independent diagnostic testing facility for sleep, respiratory, and cardiac conditions. The acquisition aims to expand access to diagnosis and enhance digital care, with financial terms undisclosed. VirtuOx will operate as a fully owned subsidiary.ResMedResmed Acquires VirtuOxResmed has acquired VirtuOx, a diagnostic testing facility, to enhance its virtual care services and expand access to diagnosis for sleep, respiratory, and cardiac conditions. The acquisition aims to make care more accessible and integrated, supporting earlier diagnosis and treatment support through digital solutions.